Durability of biochemical improvements through six years of open label treatment with obeticholic acid in patients with PBC who did not achieve the POISE criteria

Authors :: D.E.J. Jones
Gideon M. Hirschfield
M. Trauner
Marco Carbone
Andreas E. Kremer
Alexander Liberman
Bettina E. Hansen
L Mac Conell
E. Smoot Malecha
Source :: DGVS Digital: BEST OF DGVS.
Publication Year :: 2020
Publisher :: © Georg Thieme Verlag KG, 2020.

Subjects :: medicine.medical_specialty
chemistry.chemical_compound
chemistry
business.industry
Internal medicine
OPEN LABEL TREATMENT
medicine
Obeticholic acid
In patient
business
Gastroenterology
Durability

Tools